347 related articles for article (PubMed ID: 14647973)
21. Adrenoceptor genes in human obesity.
Arner P; Hoffstedt J
J Intern Med; 1999 Jun; 245(6):667-72. PubMed ID: 10395196
[TBL] [Abstract][Full Text] [Related]
22. beta2- and beta3-Adrenoceptor polymorphisms relate to subsequent weight gain and blood pressure elevation in obese normotensive individuals.
Kawaguchi H; Masuo K; Katsuya T; Sugimoto K; Rakugi H; Ogihara T; Tuck ML
Hypertens Res; 2006 Dec; 29(12):951-9. PubMed ID: 17378367
[TBL] [Abstract][Full Text] [Related]
23. Variants in the human beta 1-, beta 2-, and beta 3-adrenergic receptor genes are not associated with morbid obesity in children and adolescents.
Tafel J; Branscheid I; Skwarna B; Schlimme M; Morcos M; Algenstaedt P; Hinney A; Hebebrand J; Nawroth P; Hamann A
Diabetes Obes Metab; 2004 Nov; 6(6):452-5. PubMed ID: 15479221
[TBL] [Abstract][Full Text] [Related]
24. Genetic variants of beta(1)-adrenoceptor gene polymorphisms (Ser49Gly and Arg389Gly) and essential hypertension in a south Indian Tamil population.
Ramu P; Rajan S; Shewade DG; Swaminathan RP; Dutta TK; Balachander J; Adithan C
Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):576-82. PubMed ID: 19673943
[TBL] [Abstract][Full Text] [Related]
25. Influence of ADRB2 Gln27Glu and ADRB3 Trp64Arg polymorphisms on body weight and body composition changes after a controlled weight-loss intervention.
Szendrei B; González-Lamuño D; Amigo T; Wang G; Pitsiladis Y; Benito PJ; Gomez-Candela C; Calderón FJ; Cupeiro R;
Appl Physiol Nutr Metab; 2016 Mar; 41(3):307-14. PubMed ID: 26888112
[TBL] [Abstract][Full Text] [Related]
26. Beta2-adrenoceptor polymorphisms and obstructive airway diseases: important issues of study design.
Yang IA; Ng T; Molenaar P; Fong KM
Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1029-36. PubMed ID: 17714090
[TBL] [Abstract][Full Text] [Related]
27. Genetic influences of beta-adrenoceptor polymorphisms on arterial functional changes and cardiac remodeling in hypertensive patients.
Yuan M; Ohishi M; Ito N; Sugimoto K; Takagi T; Terai M; Katsuya T; Rakugi H; Wu Z; Ogihara T
Hypertens Res; 2006 Nov; 29(11):875-81. PubMed ID: 17345787
[TBL] [Abstract][Full Text] [Related]
28. Role of beta1- and beta2-adrenoceptor polymorphisms in heart failure: a case-control study.
Covolo L; Gelatti U; Metra M; Nodari S; Piccichè A; Pezzali N; Zani C; Alberti A; Donato F; Nardi G; Dei Cas L
Eur Heart J; 2004 Sep; 25(17):1534-41. PubMed ID: 15342173
[TBL] [Abstract][Full Text] [Related]
29. {beta}-Adrenoceptor gene variation and intermediate physiological traits: prediction of distant phenotype.
Eisenach JH; Wittwer ED
Exp Physiol; 2010 Jul; 95(7):757-64. PubMed ID: 20382665
[TBL] [Abstract][Full Text] [Related]
30. Is there a role of the Thr164Ile-beta(2)-adrenoceptor polymorphism for the outcome of chronic heart failure?
Leineweber K; Tenderich G; Wolf C; Wagner S; Zittermann A; Elter-Schulz M; Moog R; Müller N; Jakob HG; Körfer R; Philipp T; Heusch G; Brodde OE
Basic Res Cardiol; 2006 Nov; 101(6):479-84. PubMed ID: 16783489
[TBL] [Abstract][Full Text] [Related]
31. Comparison of three radioligands for the labelling of human beta-adrenoceptor subtypes.
Niclauss N; Michel-Reher MB; Alewijnse AE; Michel MC
Naunyn Schmiedebergs Arch Pharmacol; 2006 Nov; 374(2):99-105. PubMed ID: 17028849
[TBL] [Abstract][Full Text] [Related]
32. Beta1- and beta2-adrenergic receptor polymorphisms affect susceptibility to idiopathic dilated cardiomyopathy.
Forleo C; Sorrentino S; Guida P; Romito R; De Tommasi E; Iacoviello M; Pitzalis M
J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):589-95. PubMed ID: 17667029
[TBL] [Abstract][Full Text] [Related]
33. Polymorphisms of β 1-adrenoreceptor gene and cardiovascular complications in patients with thyrotoxicosis.
Babenko AY; Grineva EN; Savitskaja DA; Kravchuk EN; Solncev VN; Kostareva AA
Biomed Res Int; 2014; 2014():402897. PubMed ID: 24982877
[TBL] [Abstract][Full Text] [Related]
34. Association of polymorphisms in the beta-2 and beta-3 adrenoceptor genes with risk of colorectal cancer in Japanese.
Takezaki T; Hamajima N; Matsuo K; Tanaka R; Hirai T; Kato T; Ohashi K; Tajima K
Int J Clin Oncol; 2001 Jun; 6(3):117-22. PubMed ID: 11706779
[TBL] [Abstract][Full Text] [Related]
35. Beta-1 and beta-2 adrenoceptor polymorphisms: functional importance, impact on cardiovascular diseases and drug responses.
Brodde OE
Pharmacol Ther; 2008 Jan; 117(1):1-29. PubMed ID: 17916379
[TBL] [Abstract][Full Text] [Related]
36. Cardiostimulant and cardiodepressant effects through overexpressed human beta2-adrenoceptors in murine heart: regional differences and functional role of beta1-adrenoceptors.
Heubach JF; Blaschke M; Harding SE; Ravens U; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 2003 Apr; 367(4):380-90. PubMed ID: 12690430
[TBL] [Abstract][Full Text] [Related]
37. Beta-2 adrenergic receptor gene polymorphisms Gln27Glu, Arg16Gly in patients with heart failure.
Mansur AJ; Fontes RS; Canzi RA; Nishimura R; Alencar AP; de Lima AC; Krieger JE; Pereira AC
BMC Cardiovasc Disord; 2009 Nov; 9():50. PubMed ID: 19886995
[TBL] [Abstract][Full Text] [Related]
38. Beta-adrenoceptor subtypes and their desensitization mechanisms.
Summers RJ; Kompa A; Roberts SJ
J Auton Pharmacol; 1997 Dec; 17(6):331-43. PubMed ID: 9610428
[No Abstract] [Full Text] [Related]
39. Beta-adrenoceptor polymorphisms and heart failure.
Lohse MJ
Trends Mol Med; 2004 Feb; 10(2):55-8. PubMed ID: 15106619
[TBL] [Abstract][Full Text] [Related]
40. Additive effect of polymorphisms in the β2 -adrenoceptor and NADPH oxidase p22 phox genes contributes to the loss of estimated glomerular filtration rate in Chinese.
Wang T; Zhang Y; Ma J; Feng Z; Niu K; Liu B
Clin Exp Pharmacol Physiol; 2014 Sep; 41(9):657-62. PubMed ID: 24890187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
